Dr. Chase Griffing Clemesha, MD

Dr. Clemesha practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Clemesha's NPI, 1407474174, was assigned on July 9, 2020. Dr. Clemesha graduated from Keck School of Medicine of USC in 2020. Dr. Clemesha holds Florida license ME160679.

Dr. Clemesha's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Clemesha's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Clemesha is also affiliated with AdventHealth Orlando. The medical group on file is Emergency Physicians of Central Florida. Dmand AI also links Dr. Clemesha to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clemesha practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Clemesha's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Clemesha is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Clemesha is licensed in Florida.

CMS data shows 421 Medicare services from Dr. Clemesha across 5 procedure codes in 2024, for 306 Medicare patients. Medicare paid $43,925 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 306 Medicare patients who saw Dr. Clemesha in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clemesha's median patient age at 41, with 57% women.

In 2024, Dr. Clemesha wrote 206 Medicare Part D claims for 140 patients. 93% of them were for generic drugs. CMS names the drug for 114 of them, across 6 drugs with 11 or more claims each, at $600 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Clemesha for performance year 2024, reported as part of a group. Dr. Clemesha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Clemesha, published from 2018 to 2019. Dr. Clemesha's most frequent co-authors are Lisa V. Rubenstein, MD, Mary Katherine Samplaski, MD and Barbara J. Turner, MD.

CMS Open Payments shows 2 general payments to Dr. Clemesha from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $130.

Dmand AI lists 1 award for Dr. Clemesha.

Dr. Clemesha graduated from Keck School of Medicine of USC in 2020.

Dr. Clemesha is in network with 4 carriers, including Excellus BlueCross BlueShield, CMS Medicare and GA State Medicaid. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.